Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 22,492 | 45,540 | 28,188 | 25,367 | 27,666 |
| Cost of Goods | 12,118 | 21,352 | 14,775 | 14,213 | 14,064 |
| Gross Profit | 10,374 | 24,188 | 13,413 | 11,154 | 13,602 |
| Operating Expenses | 40,753 | 84,722 | 35,574 | 32,539 | 31,115 |
| Operating Income | -30,261 | -60,182 | -21,386 | -21,172 | -17,449 |
| Interest Expense | 858 | 1,033 | 0 | 0 | 0 |
| Other Income | 5,714 | 29,186 | 1,448 | 225 | 710 |
| Pre-tax Income | -25,405 | -32,029 | -19,938 | -20,947 | -16,739 |
| Income Tax | 39 | 128 | -162 | 50 | 301 |
| Net Income Continuous | -25,444 | -32,157 | -19,776 | -20,997 | -17,040 |
| Net Income Discontinuous | -20,274 | N/A | N/A | N/A | N/A |
| Net Income | $-45,718 | $-32,157 | $-19,776 | $-20,997 | $-17,040 |
| EPS Basic Total Ops | -0.12 | -0.27 | -0.24 | -0.27 | -0.22 |
| EPS Basic Continuous Ops | -0.07 | -0.11 | -0.25 | -0.27 | -0.22 |
| EPS Basic Discontinuous Ops | -0.05 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.12 | -0.27 | -0.24 | -0.27 | -0.22 |
| EPS Diluted Continuous Ops | -0.07 | -0.11 | -0.25 | -0.27 | -0.22 |
| EPS Diluted Discontinuous Ops | -0.05 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.26 | -0.12 | N/A | N/A |
| EBITDA(a) | $-28,289 | $-57,648 | $-18,420 | $-17,356 | $-13,809 |